StocksMedium•4 November 2026•
1 min read
AC Immune Reports Narrower-Than-Expected Q3 2026 Loss
Key Facts
1AC Immune reported a quarterly loss of $0.16 per share, narrower than the Zacks Consensus Estimate of a $0.22 loss.
2The current quarter's results represent an improvement compared to a loss of $0.20 per share reported a year ago.
AC Immune reported a quarterly loss of $0.16 per share for the third quarter of 2026. Zacks reported that these results were narrower than the consensus estimate of a $0.22 loss per share, with the company also beating revenue expectations for the period.
The current quarter's performance represents an improvement over the $0.20 per share loss reported during the same period last year. Shares of AC Immune, trading under the ticker ACIU, closed at $2.09 on November 3, 2026.